{
  "date": "2018-10-29T11:24:23.823096", 
  "open_access": true, 
  "target_url": "http://www.nice.org.uk/nicemedia/pdf/TA168fullguidance.pdf", 
  "description": "", 
  "end_date": null, 
  "title": "National Institute for Health and Clinical Excellence (NICE): technology appraisal guidance 168 - Amantadine, oseltamivir and zanamivir for the treatment of influenza (February 2009)", 
  "record_id": "20181029T112423/H8d3bUC9nrTdNq52Sft3Rw==", 
  "publisher": "nice.org.uk", 
  "start_date": null, 
  "subject": "Pandemic Influenza"
}

# National Institute for Health and Clinical Excellence (NICE): technology appraisal guidance 168 - Amantadine, oseltamivir and zanamivir for the treatment of influenza (February 2009)

